Skip to main content
Premium Trial:

Request an Annual Quote

Firms Launch Collaboration for Protein Kinase Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The formation of the Kinomed Partnership was announced today to provide integrated services for protein kinase inhibitor discovery and development and other research.

The European partnership comprises Iota Pharmaceuticals, protein research firm KinaseDetect, and drug discovery firm SARomics Biostructures.

Other services the partnership is offering include kinase production, kinase assay development, kinase crysal structure determination, kinase fragment library construction, hit finding and optimization, in silico screening, kinase biochemical and biophysical screening, structure- and ligand-based drug design, and medicinal chemistry.

Funding for the partnership comes from the Eurostars program of the European Union.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.